Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

23 October 2023
Charlie Massey, Chief Executive and Registrar of the General Medical Council, introduces the new standards for doctors which focus on building successful teams and positive, open cultures across...
23 October 2023
In this snapshot article, we look at insights around the protected characteristics of age, disability, gender reassignment and sex to help encourage learning and discussions in pharmacy teams Under...
23 October 2023
See our resources for help to meet your professional responsibilities The duty of candour – the responsibility to be open and honest with patients when something goes wrong – continues to be one of...
22 June 2023
Help us evaluate our five-year strategy for changing the way we manage concerns about pharmacy professionals In June 2021, we published our five-year strategy- Managing concerns about pharmacy...
22 June 2023
The RPS would like to hear from pharmacists, pharmacy technicians and the wider pharmacy team to help contribute to the RPS’ Inclusion and Diversity Strategy. Working with partners across the system...